OUR PRODUCTS

MOBILE APPS

GENERAL INFO

RCUS

Stock ticker: NYSE

PRICE

CHANGE

CAPITALIZATION

Arcus Biosciences (RCUS) Earnings Date & Reports

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

RCUS is expected to report earnings to fall ∞% to -116 cents per share on November 11

Arcus Biosciences RCUS Stock Earnings Reports

Q3'25

Est.

$-1.17

Q2'25

Beat

by $1.12

Q1'25

Missed

by $0.12

Q4'24

Beat

by $0.20

Q3'24

Beat

by $0.02

The last earnings report on August 06 showed earnings per share of 0 cents, beating the estimate of -112 cents. With 751.01K shares outstanding, the current market capitalization sits at 964.26M.

View a ticker or compare two or three

Compare

RCUS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For RCUS
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RCUS showed earnings on August 06, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a company which offers pre-clinical drug discovery and development solutions

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

3928 Point Eden Way

Phone

+1 510 694-6200

Employees

577

Web

https://www.arcusbio.com